Pfizer’s parent company acquires Array BioPharma

18 Jun 2019 Evaluate

Pfizer’s parent company -- Pfizer Inc., USA, has acquired Array BioPharma, a biotechnology firm that specializes in cancer drugs. The company has offered $48 per share in cash for Array, putting $11.4 billion value on the company.

The proposed acquisition sets the stage to create a potentially industry-leading franchise for colorectal cancer alongside the company’s existing expertise in breast and prostate cancers.

Pfizer has produced innovative breakthroughs in a wide range of research areas, including depression, erectile dysfunction, high cholesterol, HIV infection, hypertension, bacterial infections and systemic fungal infections.

Pfizer Share Price

5269.35 47.30 (0.91%)
25-Nov-2024 13:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1791.00
Dr. Reddys Lab 1216.45
Cipla 1492.95
Lupin 2102.40
Zydus Lifesciences 955.05
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.